HIWU Horsemen’s Advisory: Compound Products
HISA Press Release
LEXINGTON, Ky.– The Horseracing Integrity and Safety Authority (HISA) has submitted proposed rule changes to its Anti-Doping and Medication Control (ADMC) Program to the Federal Trade Commission (FTC) for review. Red-lined documents noting these proposed changes are available here:
- Rule Series 1000 – General Provisions
- Rule Series 3000 – Protocol
- Rule Series 4000 – Prohibited List
- Rule Series 5000 – Testing and Investigation Standards
- Rule Series 6000 – Laboratory Standards
- Rule Series 7000 – Arbitration Rules
The FTC will subsequently post the proposed rules to the federal register for public comment.
Until changes to the rules are approved by the FTC, the previously approved version of HISA’s ADMC rules, which took effect May 22, 2023, will remain in place. Those rules are available in full on HISA’s Regulations Page.
Similar to the proposed Racetrack Safety rule changes which HISA submitted to the FTC in September, the proposed changes to the ADMC rules were developed after months of dialogue with and feedback from racing participants across the country, including HISA’s Horsemen’s Advisory Group. During this time, the proposed rules were shared with industry members for informal comments and published on HISA’s website for additional industry input. The proposed changes submitted to the FTC today were reviewed and approved by HISA’s ADMC Committee and full Board of Directors.
When and if these rule changes are approved by the FTC, HISA will undertake robust educational efforts to ensure horsemen nationwide are fully aware of these changes and well-equipped to comply with them before they go into effect.
HIWU Horsemen’s Advisory:
Compound Products
